近年来,在生物化学方面诊断心肌梗塞、测定病人血中肌红蛋白(Mb)浓度,已经得到广泛地应用。与GOT、LDH和CPK等不同,Mb较早的从梗塞区游离入血,且其血液浓度改变较大。因此,能较早的诊断梗塞区心肌坏死性改变,并提高诊断的准确性。 患者血中Mb的游离,在很大大程度上是通过与其抗体的联系实现的。Mb的浓度不仅决定于其在血中的含量,而且也决定于其不和抗体结合的水平。血中Mb抗体含量越多,则一般地其与抗体结合的越多。因 In recent years, biochemical diagnosis of myocardial infarction, determination of the patient’s blood myoglobin (Mb) concentration, has been widely used. Unlike GOT, LDH, and CPK, Mb is released from the infarct area earlier and changes its blood concentration significantly. Therefore, the early diagnosis of myocardial infarction infarction changes, and improve the accuracy of diagnosis. The dissociation of Mb in the patient’s blood is largely mediated by its association with the antibody. The concentration of Mb depends not only on its content in the blood, but also on the level at which it does not bind to the antibody. The higher the Mb content in the blood, the more typically it binds to the antibody. because